placebo: yellow

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents effect
Weight: 0.53
, thing
Weight: 0.50
, act
Weight: 0.48
, band
Weight: 0.48
, drug
Weight: 0.47
Siblings vancomycin
Weight: 0.33
, ibuprofen
Weight: 0.32
, bupropion
Weight: 0.32
, warfarin
Weight: 0.32
, metronidazole
Weight: 0.32

Related properties

Property Similarity
yellow 1.00
has color yellow 0.92

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.12
Rule weight: 0.13
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.30
¬ Remarkable(placebo, yellow)
Evidence: 0.42
¬ Remarkable(vancomycin, yellow)
0.10
Rule weight: 0.13
Evidence weight: 0.84
Similarity weight: 0.92
Evidence: 0.30
¬ Remarkable(placebo, yellow)
Evidence: 0.54
¬ Remarkable(vancomycin, has color yellow)
0.10
Rule weight: 0.13
Evidence weight: 0.79
Similarity weight: 0.92
Evidence: 0.30
¬ Remarkable(placebo, yellow)
Evidence: 0.69
¬ Remarkable(metronidazole, has color yellow)

Remarkability from sibling implausibility

0.52
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 1.00
Evidence: 0.46
Plausible(placebo, yellow)
Evidence: 0.42
Remarkable(vancomycin, yellow)
Evidence: 0.43
¬ Plausible(vancomycin, yellow)
0.49
Rule weight: 0.60
Evidence weight: 0.89
Similarity weight: 0.92
Evidence: 0.46
Plausible(placebo, yellow)
Evidence: 0.69
Remarkable(metronidazole, has color yellow)
Evidence: 0.66
¬ Plausible(metronidazole, has color yellow)
0.47
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 0.92
Evidence: 0.46
Plausible(placebo, yellow)
Evidence: 0.54
Remarkable(vancomycin, has color yellow)
Evidence: 0.58
¬ Plausible(vancomycin, has color yellow)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.46
Plausible(placebo, yellow)
Evidence: 0.36
¬ Salient(placebo, yellow)

Similarity expansion

0.53
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.92
Evidence: 0.63
Typical(placebo, yellow)
Evidence: 0.88
¬ Typical(placebo, has color yellow)
0.48
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.92
Evidence: 0.30
Remarkable(placebo, yellow)
Evidence: 0.57
¬ Remarkable(placebo, has color yellow)
0.44
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.92
Evidence: 0.46
Plausible(placebo, yellow)
Evidence: 0.82
¬ Plausible(placebo, has color yellow)
0.35
Rule weight: 0.85
Evidence weight: 0.44
Similarity weight: 0.92
Evidence: 0.36
Salient(placebo, yellow)
Evidence: 0.88
¬ Salient(placebo, has color yellow)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.36
Salient(placebo, yellow)
Evidence: 0.63
¬ Typical(placebo, yellow)
Evidence: 0.30
¬ Remarkable(placebo, yellow)

Typical implies Plausible

0.31
Rule weight: 0.48
Evidence weight: 0.66
Similarity weight: 1.00
Evidence: 0.46
Plausible(placebo, yellow)
Evidence: 0.63
¬ Typical(placebo, yellow)

Typicality and Rermarkability incompatibility between siblings

0.11
Rule weight: 0.14
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.30
¬ Remarkable(placebo, yellow)
Evidence: 0.53
¬ Typical(vancomycin, yellow)
0.10
Rule weight: 0.14
Evidence weight: 0.80
Similarity weight: 0.92
Evidence: 0.30
¬ Remarkable(placebo, yellow)
Evidence: 0.64
¬ Typical(vancomycin, has color yellow)
0.10
Rule weight: 0.14
Evidence weight: 0.80
Similarity weight: 0.92
Evidence: 0.30
¬ Remarkable(placebo, yellow)
Evidence: 0.67
¬ Typical(metronidazole, has color yellow)